About Sam Barnum

This author has not yet filled in any details.
So far Sam Barnum has created 21 blog entries.

Navigating the Italian HTA Process: Essentials to a Favorable Review

2020-01-16T13:37:20-05:00

From November 1, 2016 to September 1, 2019, the Italian Medicines Agency, AIFA evaluated a total of 166 Dossiers - 28 were related to orphan drugs, 56 to new active substances, 57 to extensions of indications for drugs already reimbursed, and 25 to other types of negotiations.

Navigating the Italian HTA Process: Essentials to a Favorable Review2020-01-16T13:37:20-05:00

DTx Part I: Identifying Optimal Payment Models for Digital Therapeutics

2020-01-14T16:08:38-05:00

The field of DTx has gained traction over the last couple of years, with FDA approvals/clearances, the founding of a DTx specialty society, large-scale acquisitions of DTx firms, pharma investments in DTx, and pharma co-development deals, amongst other key developments.

DTx Part I: Identifying Optimal Payment Models for Digital Therapeutics2020-01-14T16:08:38-05:00

ICER Set to Evaluate Non-Drug Products in 2020

2020-01-14T09:19:17-05:00

The Boston-based Institute for Clinical and Economic Review (ICER) recently announced that in 2020, they are considering selecting two or more non-drug topics for assessment.

ICER Set to Evaluate Non-Drug Products in 20202020-01-14T09:19:17-05:00

Germany Paves the Way for Reimbursement of Digital Health Care Apps

2019-10-31T16:03:50-04:00

In Germany, doctors could potentially be prescribing health apps as medicines as early as 2020. This is one of the main objectives of the draft bill on the “Law for better provision through digitalization and innovation”, which is expected to be approved by the parliament early November.

Germany Paves the Way for Reimbursement of Digital Health Care Apps2019-10-31T16:03:50-04:00

New Independent Medical Review Board for Germany

2019-09-11T14:49:42-04:00

For medical device and diagnostic innovators, a planned organizational change in review boards for Germany’s Statutory Health Insurance (SHI) could lead to new opportunities for market access of their products.

New Independent Medical Review Board for Germany2019-09-11T14:49:42-04:00

Winter Has Come – Aggressive National Programs To Drive Down Drug Costs

2019-09-11T14:48:29-04:00

China: 2018 was another eventful year for the pharmaceutical industry, highlighted by the Chinese government’s radical attempts to slash drug prices by the annual national drug price negotiation and along with the introduction of a national procurement program.

Winter Has Come – Aggressive National Programs To Drive Down Drug Costs2019-09-11T14:48:29-04:00

The Evolution of Medical Device Procurement in Italy

2019-09-11T15:21:31-04:00

Assobiomedica, the body representing the medical device sector in Italy, published an update to the report ‘Public Policies for the Purchase of Medical Devices’ in October 2018. Boston healthcare outline procurement trend in the Italian reimbursement environment.

The Evolution of Medical Device Procurement in Italy2019-09-11T15:21:31-04:00

Defining the value of innovative treatment methods in Germany

2019-09-11T15:22:46-04:00

A recent proposal by Jens Spahn, Federal Minister for Health in Germany, would limit the decision-making power of the Joint Federal Committee (G-BA) and lead to new evidence approaches for healthcare decision making.

Defining the value of innovative treatment methods in Germany2019-09-11T15:22:46-04:00

FDA Issues New Draft Guidance on Class Labeling of Companion Diagnostics

2019-09-11T15:23:59-04:00

Earlier this month, the Food and Drug Administration announced a new draft guidance for companion diagnostics. The guidance describes considerations for the development and labeling of companion diagnostics to support the indicated uses of multiple therapeutic oncology products.

FDA Issues New Draft Guidance on Class Labeling of Companion Diagnostics2019-09-11T15:23:59-04:00

Access our presentations: MedTech Access Leaders Forum, EU

2019-09-11T14:46:23-04:00

Boston Healthcare spoke at the MedTech Access Leaders Forum in Berlin, Germany on 3-5 December 2018. Vice President, Rob Wenthold spoke on maximizing the organizational impact of the market access function, and CEO, Joe Ferrara spoke on global considerations for companion diagnostics. Register your details to receive your copy!

Access our presentations: MedTech Access Leaders Forum, EU2019-09-11T14:46:23-04:00